<table border="1" id="id_6c2afd3a-9ca1-4672-8240-fd2ce2ee9463" width="390.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_8a26d1ce-a5f0-4572-8562-b79677bf92e7">Table 16. Mean Pharmacokinetic Parameters in Pediatric Patients With Epilepsy</caption>
<col width="32.6%"></col>
<col width="17.9%"></col>
<col width="13.8%"></col>
<col width="12.3%"></col>
<col width="23.3%"></col>
<tbody>
<tr id="id_5260108b-6791-45de-af81-ac35ae1e1424">
<td align="center" stylecode="Botrule Toprule Rrule Lrule" valign="middle"> Pediatric Study Population </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> Number of Subjects </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> T<sub>max</sub> (hr) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> t<sub>½</sub> (hr) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> Cl/F (mL/min/kg) </td>
</tr>
<tr id="id_9125bec6-fd5e-4004-a8ab-dfbca89fa3d5">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">Ages 10 months to 5.3 years</content>
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="left" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="left" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="left" stylecode="Botrule Rrule" valign="middle">   </td>
</tr>
<tr id="id_0d0046eb-fb82-47ae-b5b2-5c891e240cb4">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnote id="id-90ca1bb1-ac35-4559-8634-0c91762fbb75">Carbamazepine, phenobarbital, phenytoin, and primidone have been shown to increase the apparent clearance of lamotrigine. Estrogen-containing oral contraceptives and rifampin have also been shown to increase the apparent clearance of lamotrigine [<content stylecode="italics">see Drug Interactions (<linkhtml href="#i4i_interactions_id_633115f7-f213-4f13-80fb-72e4ce892318">7</linkhtml>)</content>].</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 10 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 3.0 (1.0 to 5.9) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 7.7 (5.7 to 11.4) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 3.62 (2.44 to 5.28) </td>
</tr>
<tr id="id_cda117dd-2edd-490b-8949-ff3948e68f8c">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking AEDs with no known effect on the apparent clearance of lamotrigine </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 7 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 5.2 (2.9 to 6.1) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 19.0 (12.9 to 27.1) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 1.2 (0.75 to 2.42) </td>
</tr>
<tr id="id_6a838882-0543-422c-8280-96d216749736">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking valproate only </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 8 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 2.9 (1.0 to 6.0) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 44.9 (29.5 to 52.5) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 0.47 (0.23 to 0.77) </td>
</tr>
<tr id="id_5c8ec77e-a402-4f6b-becc-cc7fad1a5e39">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">Ages 5 to 11 years</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
</tr>
<tr id="id_ba9c80b2-e97d-480d-9e37-565bd4f64a87">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-90ca1bb1-ac35-4559-8634-0c91762fbb75"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 7 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 1.6 (1.0 to 3.0) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 7.0 (3.8 to 9.8) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 2.54 (1.35 to 5.58) </td>
</tr>
<tr id="id_996b68bd-e8b7-465d-b4b9-72133c95246a">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-90ca1bb1-ac35-4559-8634-0c91762fbb75"></footnoteref> plus valproate </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 8 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 3.3 (1.0 to 6.4) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 19.1 (7.0 to 31.2) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 0.89 (0.39 to 1.93) </td>
</tr>
<tr id="id_5705986d-ce21-4355-a3d2-baee2b44ca55">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking valproate only<footnote id="id-e330e132-4ee6-4e1c-bac8-d40e47e85150">Two subjects were included in the calculation for mean T<sub>max</sub>.</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 3 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 4.5 (3.0 to 6.0) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 65.8 (50.7 to 73.7) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 0.24 (0.21 to 0.26) </td>
</tr>
<tr id="id_feff4dd6-e9af-4b91-a8c8-1fd02087cded">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">Ages 13 to 18 years</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
</tr>
<tr id="id_580f802f-40fa-43f2-a21e-67fccadceb2c">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-90ca1bb1-ac35-4559-8634-0c91762fbb75"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 11 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<footnote id="id-71c980c7-510b-4bc9-810d-5d69277f56d8">Parameter not estimated.</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<footnoteref idref="id-71c980c7-510b-4bc9-810d-5d69277f56d8"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 1.3 </td>
</tr>
<tr id="id_241b512f-8f75-4888-850a-8769f94c8537">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-90ca1bb1-ac35-4559-8634-0c91762fbb75"></footnoteref> plus valproate </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 8 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<footnoteref idref="id-71c980c7-510b-4bc9-810d-5d69277f56d8"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<footnoteref idref="id-71c980c7-510b-4bc9-810d-5d69277f56d8"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 0.5 </td>
</tr>
<tr id="id_d9abea8b-e289-4c29-a9a2-0f931a43c56a">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking valproate only </td>
<td align="center" stylecode="Rrule" valign="middle"> 4 </td>
<td align="center" stylecode="Rrule" valign="middle">
<footnoteref idref="id-71c980c7-510b-4bc9-810d-5d69277f56d8"></footnoteref>
</td>
<td align="center" stylecode="Rrule" valign="middle">
<footnoteref idref="id-71c980c7-510b-4bc9-810d-5d69277f56d8"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 0.3 </td>
</tr>
</tbody>
</table>